These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21195908)

  • 21. Mechanisms of malnutrition in uremia.
    Guarnieri G; Antonione R; Biolo G
    J Ren Nutr; 2003 Apr; 13(2):153-7. PubMed ID: 12671841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Obesity in dialysis and reverse epidemiology: true or false?].
    Panzetta G; Abaterusso C
    G Ital Nefrol; 2010; 27(6):629-38. PubMed ID: 21132645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
    Chalmers L; Kaskel FJ; Bamgbola O
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients.
    Suliman ME; Lindholm B; Bárány P; Qureshi AR; Stenvinkel P
    Semin Dial; 2007; 20(6):523-9. PubMed ID: 17991198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of malnutrition in uremia.
    Guarnieri G; Toigo G; Fiotti N; Ciocchi B; Situlin R; Giansante C; Vasile A; Carraro M; Faccini L; Biolo G
    Kidney Int Suppl; 1997 Nov; 62():S41-4. PubMed ID: 9350678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein and energy intake in advanced chronic kidney disease: how much is too much?
    Ikizler TA
    Semin Dial; 2007; 20(1):5-11. PubMed ID: 17244111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Strong connection between malnutrition, inflammation and arteriosclerosis. Improved treatment of renal failure if underlying factors are attacked].
    Efendic E; Lindholm B; Bergström J; Stenvinkel P
    Lakartidningen; 1999 Oct; 96(42):4538-42. PubMed ID: 10575860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic syndrome and chronic kidney disease.
    Guarnieri G; Zanetti M; Vinci P; Cattin MR; Pirulli A; Barazzoni R
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S19-23. PubMed ID: 20797564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis.
    Cordeiro AC; Qureshi AR; Stenvinkel P; Heimbürger O; Axelsson J; Bárány P; Lindholm B; Carrero JJ
    Nephrol Dial Transplant; 2010 Feb; 25(2):562-8. PubMed ID: 19762603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of protein kinetics in chronic renal failure.
    Guarnieri G; Toigo G; Situlin R; Ciocchi B; Biolo G
    Miner Electrolyte Metab; 1997; 23(3-6):214-7. PubMed ID: 9387120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patients.
    Guo Q; Bárány P; Qureshi AR; Snaedal S; Heimburger O; Stenvinkel P; Lindholm B; Axelsson J
    Am J Nephrol; 2009; 29(6):516-23. PubMed ID: 19077418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
    Black PH
    Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inflammation and insulin resistance: chronic renal disease features].
    Guebre-Egziabher F; Juillard L; Kalbacher E; Bachetta J; Fouque D
    Nephrol Ther; 2010 Feb; 6 Suppl 1():S7-12. PubMed ID: 20172498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inflammation and nutritional status in haemodialysis patients].
    Tirmenstajn-Janković B; Dimković N; Zivanović M
    Med Pregl; 2007; 60 Suppl 2():137-41. PubMed ID: 18928180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is ghrelin a biomarker for mortality in end-stage renal disease?
    Mak RH; Cheung WW
    Kidney Int; 2011 Apr; 79(7):697-9. PubMed ID: 21403653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of fat mass and adipokines in chronic kidney disease.
    Axelsson J; Stenvinkel P
    Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):25-31. PubMed ID: 18090666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammation in end-stage renal disease--what have we learned in 10 years?
    Carrero JJ; Stenvinkel P
    Semin Dial; 2010; 23(5):498-509. PubMed ID: 21039875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malnutrition in hemodialysis patients: what therapy?
    Bossola M; Muscaritoli M; Tazza L; Giungi S; Tortorelli A; Rossi Fanelli F; Luciani G
    Am J Kidney Dis; 2005 Sep; 46(3):371-86. PubMed ID: 16129199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher total ghrelin levels are associated with higher insulin-mediated glucose disposal in non-diabetic maintenance hemodialysis patients.
    Barazzoni R; Zanetti M; Stulle M; Mucci MP; Pirulli A; Dore F; Panzetta G; Vasile A; Biolo G; Guarnieri G
    Clin Nutr; 2008 Feb; 27(1):142-9. PubMed ID: 17854954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel approaches in an integrated therapy of inflammatory-associated wasting in end-stage renal disease.
    Stenvinkel P; Lindholm B; Heimbürger O
    Semin Dial; 2004; 17(6):505-15. PubMed ID: 15660582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.